Cargando…
Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned
New technologies and disruptions related to Coronavirus disease-2019 have led to expansion of decentralized approaches to clinical trials. Remote tools and methods hold promise for increasing trial efficiency and reducing burdens and barriers by facilitating participation outside of traditional clin...
Autores principales: | Hanley, Daniel F., Bernard, Gordon R., Wilkins, Consuelo H., Selker, Harry P., Dwyer, Jamie P., Dean, J. Michael, Benjamin, Daniel Kelly, Dunsmore, Sarah E., Waddy, Salina P., Wiley, Kenneth L., Palm, Marisha E., Mould, W. Andrew, Ford, Daniel F., Burr, Jeri S., Huvane, Jacqueline, Lane, Karen, Poole, Lori, Edwards, Terri L., Kennedy, Nan, Boone, Leslie R., Bell, Jasmine, Serdoz, Emily, Byrne, Loretta M., Harris, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465321/ https://www.ncbi.nlm.nih.gov/pubmed/37654775 http://dx.doi.org/10.1017/cts.2023.597 |
Ejemplares similares
-
Approaches for enhancing the informativeness and quality of clinical trials: Innovations and principles for implementing multicenter trials from the Trial Innovation Network
por: Lane, Karen, et al.
Publicado: (2023) -
From a decentralized clinical trial to a decentralized and clinical-trial-in-a-box platform: Towards patient-centric and equitable trials
por: Dulko, Dorothy, et al.
Publicado: (2023) -
Response of the trial innovation network to the COVID-19 pandemic
por: Greenberg, Rachel G., et al.
Publicado: (2021) -
Sharing data among clinical trials of therapeutics in COVID-19: Barriers and facilitators to collaborating in a crisis
por: Palm, Marisha E., et al.
Publicado: (2021) -
The use of N-of-1 trials to generate real-world evidence for optimal treatment of individuals and populations
por: Selker, Harry P., et al.
Publicado: (2023)